venlafaxine 75 mg
1 INDICATIONS AND USAGE Venlafaxine hydrochloride extended-release capsules are indicated in adults for the treatment of: major depressive disorder (MDD) [see Clinical Studies (14.1) ] Generalized Anxiety Disorder (GAD) [see Clinical Studies (14.2) ] Social Anxiety Disorder (SAD) [see Clinical Studies (14.3) ] Panic Disorder (PD) [see Clinical Studies (14.4) ] Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: major depressive disorder (MDD) (1) Generalized Anxiety Disorder (GAD) (1) Social Anxiety Disorder (SAD) (1) Panic Disorder (PD) (1)
American Health Packaging
CAPSULE ORANGE E 74
E 74 CAPSULE ORANGE
Related Pills
venlafaxine 150 mg
American Health Packaging
venlafaxine 37.5 mg
american health packaging
Venlafaxine Hydrochloride 24 HR venlafaxine 75 MG Extended Release Oral Capsule
KAISER FOUNDATION HOSPITALS
Venlafaxine Hydrochloride 24 HR venlafaxine 75 MG Extended Release Oral Capsule
KAISER FOUNDATION HOSPITALS
Venlafaxine Hydrochloride 24 HR venlafaxine 75 MG Extended Release Oral Capsule
KAISER FOUNDATION HOSPITALS
Venlafaxine Hydrochloride 24 HR venlafaxine 75 MG Extended Release Oral Capsule
KAISER FOUNDATION HOSPITALS
Lovastatin Lovastatin 40 MG Oral Tablet
Eon Labs, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
VENLAFAXINE HYDROCHLORIDE Extended-Release capsules USP, 37.5 mg are white to off white spherical to oval pellets filled in empty hard gelatin capsule shell (size ‘3’) of opaque grey color cap and opaque peach color body imprinted with “E” on cap and “73” on the body with edible black ink. Unit dose packages of 100 (10 x 10) NDC 68084‐698‐01
VENLAFAXINE HYDROCHLORIDE Extended-Release capsules USP, 75 mg are white to off white spherical to oval pellets filled in empty hard gelatin capsule shell (size ‘1’) of opaque peach color cap and opaque peach color body imprinted with “E” on cap and “74” on the body with edible black ink. Unit dose packages of 100 (10 x 10) NDC 68084‐709‐01
VENLAFAXINE HYDROCHLORIDE Extended-Release capsules USP, 150 mg are white to off white spherical to oval pellets filled in empty hard gelatin capsule shell (size ‘0’) of opaque dark orange color cap and opaque dark orange color body imprinted with “E” on cap and “89” on the body with edible black ink. Unit dose packages of 100 (10 x 10) NDC 68084‐713‐01 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] FOR YOUR PROTECTION: Do not use if blister is torn or broken.
More pills like CAPSULE E 74